Researchers from the Yerkes National Primate Research Center have shown Zika virus infection soon after birth leads to long-term brain and behavior problems, including persistent socioemotional, cognitive and motor deficits, as well as abnormalities in brain structure and function. This study is one of the first to shed light on potential long-term effects of Zika infection after birth.
“Researchers have shown the devastating damage Zika virus causes to a fetus, but we had questions about what happens to the developing brain of a young child who gets infected by Zika,” says lead researcher Ann Chahroudi, MD, PhD, an affiliate scientist in the Division of Microbiology and Immunology at Yerkes, director of the Center for Childhood Infections and Vaccines (CCIV), Children’s Healthcare of Atlanta (CHOA) and Emory University, and an associate professor of pediatrics in the Division of Pediatric Infectious Diseases at Emory University School of Medicine. “Our pilot study in nonhuman primates provides clues that Zika virus infection during the early postnatal period can have long-lasting impact on how the brain develops and works, and how this scenario has the potential to impact child behavior,” Chahroudi continues.
The study, published online in Nature Communications, followed four infant rhesus monkeys for one year after Zika virus infection at one month of age. Studying a rhesus monkey until the age of 1 translates to the equivalent of 4 to 5 years in human age. Researchers found postnatal Zika virus infections led to Impairments in memory function, significant changes in behavior, including reduced social interactions and increased emotional reactions, and some gross motor deficits. These changes corresponded with structural and functional brain changes the researchers found on MRI scans – findings that indicate long-term neurologic complications.
“Our findings demonstrate neurodevelopmental changes detected at 3 and 6 months of age are persistent,” says first author Jessica Raper, PhD, research assistant professor at Yerkes. (See Science Translational Medicine for an earlier study by members of the current research team). “This is significant because it gives healthcare providers a better understanding of possible complications of Zika beyond infection during pregnancy and into the first years of life,” she continues.
Considering the similarities between human and nonhuman primate brain development, the rhesus monkey provides an important translational model for understanding the impact of viral infection on the human brain. While the infant brain has an extended development period that may facilitate healing after early brain damage, the current study found persistent alterations in brain growth and function as a result of the early postnatal Zika virus infection.
This research was part of Yerkes’ Pilot Research Projects program, which serves to generate initial, proof-of-concept data that will inform future studies. “Our results shed light on potential outcomes of human infants infected with Zika virus after birth and provide a platform to test treatments to alleviate long-term neurologic consequences of Zika infection,” says Chahroudi. “Our research team encourages future studies to understand the impact of early postnatal Zika infection during later stages of life, from adolescence to adulthood.”
The collaborative research team included: Yerkes and Emory: Zsofia Kovacs-Balint, Maud Mavigner, Sanjeev Gumber, Jakob Habib, Cameron Mattingly, Sherrie M. Jean, Joyce K. Cohen, Mehul S. Suthar, Mar M. Sanchez and Maria C. Alvarado; Howard University: Mark W. Burke; OHSU: Damien Fair, Eric Earl and Eric Feczko; and UNC Chapel Hill: Martin Styner.
More than 85 countries and territories have reported evidence of mosquito-acquired Zika virus infection, for which there is no cure or medications to treat it. Zika virus and the mosquitoes that transmit it have not been eliminated, and so transmission remains a risk.
Funding: The Yerkes National Primate Research Center provided funding for this study via its Pilot Research Project program. Yerkes is supported in part by the National Institutes of Health’s Office of the Director, Office of Research Infrastructures Programs, P51 OD011132. The CCIV of CHOA and Emory also provided pilot funding for the research reported in this release.
Grant amounts (direct + indirect):
P51 OD011132 $10,540,602/yr; $70,000 pilot grant/one-time award
CCIV pilot grant $50,000/one-time award
Dedicated to discovering causes, preventions, treatments and cures, Yerkes National Primate Research Center (NPRC), part of Emory University’s Robert W. Woodruff Health Sciences Center, is fighting diseases and improving human health and lives worldwide. The center, one of only seven NPRCs the National Institutes of Health (NIH) funds, is supported by $79.1 million in research funding (all sources, fiscal year 2017). Yerkes researchers are making landmark discoveries in microbiology and immunology; neurologic diseases; neuropharmacology; behavioral, cognitive, and developmental neuroscience; and psychiatric disorders. Since 1984, the center has been fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International, regarded as the gold seal of approval for laboratory animal care.
Related Journal Article